Ocular Behçet disease. Retrospective study
Torres, R.M.; Yáñez, B.; Herreras, J.M.; Calonge, M.
Archivos de la Sociedad Espanola de Oftalmologia 79(12): 599-603
2004
ISSN/ISBN: 0365-6691 PMID: 15627928 Document Number: 576539
To study clinical features, visual prognosis and response to immunosuppressive drugs in patients with ocular Behçet Disease (BD). clinical data of 17 patients (33 eyes) were retrospectively reviewed from May 1996 to May 2003. The male/female ratio was 12/5. The commonest manifestations were oral ulceration (100%) and skin lesions (88%). Anterior uveitis was present in 59%, posterior uveitis was in 76% and panuveitis was in 88.1%. Visual acuity improved in 11 (33.3%) eyes, remind stable in 18 (54.5%) eyes and four (12.1%) eyes lost two or more lines. Main drug therapy consisted of colchicine and cyclosporine (59%). Seven patients had received three drugs simultaneously. BD can lead to an irreversible visual loss; however, the visual prognosis is good (85%) if immunosuppressor treatment is implemented.